Christian H. Bergsland
Oslo, 0424, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.
Journal: Cell reports. Medicine
Published: December 11, 2025
Pembrolizumab in advanced malignant peripheral nerve sheath tumors: a single-arm phase 2 trial.
Journal: NPJ precision oncology
Published: July 02, 2025
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 12, 2024
Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 17, 2022
Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: January 22, 2022
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models.
Journal: Molecular oncology
Published: August 17, 2021
Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases.
Journal: Journal of translational medicine
Published: June 28, 2021
Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients.
Journal: British journal of cancer
Published: May 27, 2021
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer.
Journal: ESMO open
Published: September 11, 2020
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: January 04, 2020
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 05, 2019
Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: August 21, 2019
Last Updated: 09/26/2026